WINTON GROUP Ltd Acquires New Stake in Stericycle, Inc. (NASDAQ:SRCL)

WINTON GROUP Ltd bought a new stake in shares of Stericycle, Inc. (NASDAQ:SRCL - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 92,137 shares of the business services provider's stock, valued at approximately $5,356,000. WINTON GROUP Ltd owned 0.10% of Stericycle as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently made changes to their positions in SRCL. Retirement Systems of Alabama boosted its position in shares of Stericycle by 0.3% during the first quarter. Retirement Systems of Alabama now owns 116,185 shares of the business services provider's stock valued at $6,129,000 after purchasing an additional 305 shares in the last quarter. Treasurer of the State of North Carolina boosted its position in shares of Stericycle by 1.0% during the fourth quarter. Treasurer of the State of North Carolina now owns 40,838 shares of the business services provider's stock valued at $2,024,000 after purchasing an additional 400 shares in the last quarter. Mirova boosted its position in shares of Stericycle by 0.9% during the first quarter. Mirova now owns 47,345 shares of the business services provider's stock valued at $2,497,000 after purchasing an additional 428 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its position in shares of Stericycle by 6.4% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 7,447 shares of the business services provider's stock valued at $433,000 after purchasing an additional 449 shares in the last quarter. Finally, Private Advisor Group LLC boosted its position in shares of Stericycle by 8.6% during the fourth quarter. Private Advisor Group LLC now owns 5,788 shares of the business services provider's stock valued at $287,000 after purchasing an additional 459 shares in the last quarter. 98.82% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the company. Keefe, Bruyette & Woods lifted their price target on Stericycle from $135.00 to $142.00 and gave the company an "outperform" rating in a research report on Tuesday, June 4th. StockNews.com started coverage on Stericycle in a report on Monday, September 9th. They issued a "hold" rating on the stock. Royal Bank of Canada reissued a "sector perform" rating and issued a $62.00 target price (down from $69.00) on shares of Stericycle in a report on Tuesday, June 4th. Finally, Truist Financial boosted their target price on Stericycle from $50.00 to $62.00 and gave the stock a "hold" rating in a report on Tuesday, June 4th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, Stericycle currently has a consensus rating of "Hold" and a consensus price target of $74.00.

Stericycle Stock Performance

Shares of NASDAQ:SRCL traded up $0.01 during midday trading on Friday, reaching $61.71. 2,532,240 shares of the company's stock traded hands, compared to its average volume of 1,766,625. The company has a market cap of $5.73 billion, a price-to-earnings ratio of -280.50, a P/E/G ratio of 3.37 and a beta of 1.11. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.13 and a current ratio of 1.13. Stericycle, Inc. has a one year low of $37.78 and a one year high of $61.77. The stock has a 50 day moving average of $59.00 and a 200 day moving average of $54.57.

Stericycle (NASDAQ:SRCL - Get Free Report) last announced its quarterly earnings results on Thursday, July 25th. The business services provider reported $0.61 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.57 by $0.04. The firm had revenue of $661.60 million for the quarter, compared to the consensus estimate of $672.07 million. Stericycle had a return on equity of 7.94% and a net margin of 1.37%. As a group, equities research analysts anticipate that Stericycle, Inc. will post 2.29 EPS for the current fiscal year.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.